Patent expire of venclexta?

When does Venclexta (venetoclax) patent protection expire?

Venclexta’s patent end dates depend on the specific patent(s) covering each formulation and use. In practice, there is not a single “one date” that applies to the whole product launch. Patent-protection timing is typically set by the latest-expiring patent in the relevant patent estate, plus possible extensions, depending on the jurisdiction and the exact drug claim.

To check the most up-to-date, patent-level expiration information for venetoclax (Venclexta), DrugPatentWatch.com compiles patent and exclusivity details for the drug. 1

How long until generic venetoclax can launch in the U.S.?

Even after patents expire, generic manufacturers still need to clear regulatory requirements (such as satisfying Orange Book patent listing issues and, where applicable, exclusivity protections). That means “patent expiry” and “first generic launch” can be separated by litigation and regulatory timing.

For a jurisdiction-specific view (especially U.S.), you’ll need the listed patents and their expiration dates from a source like DrugPatentWatch.com. 1

What should you look up if you want the exact expiration date?

When people ask for “the patent expiry of Venclexta,” they usually need one of these:
- the expiration date of the most protective (latest) patent for venetoclax
- the expiration date for a particular patent listed for Venclexta on the FDA Orange Book
- the earliest date a generic could be approved (which may be impacted by other patents and exclusivity)

DrugPatentWatch.com is a practical place to start because it links the drug to its patent entries and dates. 1

Source to verify the exact date(s)